JPH0543505A - Styryl ketone deribvative and skin drug for external use containing the same derivative - Google Patents
Styryl ketone deribvative and skin drug for external use containing the same derivativeInfo
- Publication number
- JPH0543505A JPH0543505A JP23122991A JP23122991A JPH0543505A JP H0543505 A JPH0543505 A JP H0543505A JP 23122991 A JP23122991 A JP 23122991A JP 23122991 A JP23122991 A JP 23122991A JP H0543505 A JPH0543505 A JP H0543505A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- group
- styryl ketone
- oil
- ketone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- -1 Styryl ketone Chemical class 0.000 title claims abstract description 39
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title abstract 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims abstract description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims abstract description 5
- 125000004417 unsaturated alkyl group Chemical group 0.000 claims abstract description 4
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 3
- 238000002360 preparation method Methods 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 19
- 239000003921 oil Substances 0.000 abstract description 14
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 abstract description 14
- 150000001875 compounds Chemical class 0.000 abstract description 8
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 abstract description 7
- 229940032094 squalane Drugs 0.000 abstract description 7
- 238000002156 mixing Methods 0.000 abstract description 4
- 229920002545 silicone oil Polymers 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 2
- 239000012188 paraffin wax Substances 0.000 abstract description 2
- 239000002199 base oil Substances 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 229920001296 polysiloxane Polymers 0.000 description 15
- 239000002585 base Substances 0.000 description 12
- 230000000475 sunscreen effect Effects 0.000 description 11
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 239000000516 sunscreening agent Substances 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 239000006096 absorbing agent Substances 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 230000002335 preservative effect Effects 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 5
- 206010042496 Sunburn Diseases 0.000 description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229940057995 liquid paraffin Drugs 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- SYBYTAAJFKOIEJ-UHFFFAOYSA-N 3-Methylbutan-2-one Chemical compound CC(C)C(C)=O SYBYTAAJFKOIEJ-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 3
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 229940125898 compound 5 Drugs 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- PJGSXYOJTGTZAV-UHFFFAOYSA-N pinacolone Chemical compound CC(=O)C(C)(C)C PJGSXYOJTGTZAV-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- CSUUDNFYSFENAE-UHFFFAOYSA-N (2-methoxyphenyl)-phenylmethanone Chemical compound COC1=CC=CC=C1C(=O)C1=CC=CC=C1 CSUUDNFYSFENAE-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical class COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 1
- VUHMIPWBDMGTNL-MHCZMQLOSA-N 1,2-dimethoxy-4-[(e)-prop-1-enyl]benzene;1,2,4-trimethoxy-5-[(e)-prop-1-enyl]benzene Chemical compound COC1=CC=C(\C=C\C)C=C1OC.COC1=CC(OC)=C(\C=C\C)C=C1OC VUHMIPWBDMGTNL-MHCZMQLOSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- CNPVJWYWYZMPDS-UHFFFAOYSA-N 2-methyldecane Chemical compound CCCCCCCCC(C)C CNPVJWYWYZMPDS-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- AIAGRBSXKXJZFB-UHFFFAOYSA-N 3-methoxy-4-(2-methylpropoxy)benzaldehyde Chemical compound COC1=CC(C=O)=CC=C1OCC(C)C AIAGRBSXKXJZFB-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 150000003935 benzaldehydes Chemical class 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 125000003354 benzotriazolyl group Chemical class N1N=NC2=C1C=CC=C2* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical class C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- OYFJQPXVCSSHAI-QFPUQLAESA-N enalapril maleate Chemical compound OC(=O)\C=C/C(O)=O.C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 OYFJQPXVCSSHAI-QFPUQLAESA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000010687 lubricating oil Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 231100000018 phototoxicity Toxicity 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明の皮膚外用剤、特にUV−
A領域の紫外線吸収能を有する皮膚外用剤の改良に関す
る。BACKGROUND OF THE INVENTION The external preparation for skin of the present invention, especially UV-
The present invention relates to improvement of a skin external preparation having an ultraviolet ray absorbing ability in the A region.
【0002】[0002]
【従来の技術】太陽光線に含まれる紫外線は、皮膚科学
的には400nm〜320nmの長波長紫外線(UV−
A)、320nm〜290nmの中波長紫外線(UV−
B)、290nm以下の短波長紫外線(UV−C)に分類
される。このうち、290nm以下の波長の紫外線は、オ
ゾン層によって吸収され、地表に到達しない。地表に届
く紫外線は、人間の皮膚に様々な影響を及ぼす。地上に
まで達する紫外線の内で、UV−Bは皮膚の紅斑や水泡
を形成し、メラニン形成も促進する。一方、UV−Aは
皮膚の褐色化を惹起し、皮膚の弾力性の低下及びシワの
発生を促進し急激な老化をもたらす。また、紅斑反応の
開始を促進し、あるいはある種の患者に対してはこの反
応を増強し、更に光毒性あるいは光アレルギー反応の原
因とさえなり得る。このようなUV−Aの有害性から皮
膚を保護するために、各種紫外線吸収剤が開発されてき
た。2. Description of the Related Art Ultraviolet rays contained in sunlight are dermatologically long wavelength ultraviolet rays (UV-) of 400 nm to 320 nm.
A), 320 nm to 290 nm medium wavelength ultraviolet rays (UV-
B) Classified as short wavelength ultraviolet rays (UV-C) of 290 nm or less. Of these, ultraviolet rays having a wavelength of 290 nm or less are absorbed by the ozone layer and do not reach the surface of the earth. The ultraviolet rays that reach the surface of the earth have various effects on human skin. Among the ultraviolet rays reaching the ground, UV-B forms erythema and blisters on the skin, and also promotes melanin formation. On the other hand, UV-A induces browning of the skin, lowers the elasticity of the skin and promotes the generation of wrinkles, resulting in rapid aging. It may also accelerate the onset of the erythema reaction, or enhance this reaction for some patients, and even cause phototoxicity or even a photoallergic reaction. Various UV absorbers have been developed in order to protect the skin from such harmful effects of UV-A.
【0003】既存のUV−A域紫外線吸収剤としては、
ベンゾフェノン誘導体、ジベンゾイルメタン誘導体、ベ
ンゾトリアゾール誘導体などがUV−A吸収剤として利
用され、皮膚外用剤に配合されてきた。一方、近年紫外
線吸収剤が配合される皮膚外用剤には、その効果を持続
される必要上、汗や水浴によって容易に流れ落ちしない
耐水性に優れた流動パラフィン、スクワラン、シリコー
ン油などの非極性油基剤が広く使用されるようになって
きた。これらの基剤の採用は、耐水性機能はもちろん、
のびの良さ、さっぱり感、べとつかない等の使用性の利
点によるところも大きい。As existing UV-A region ultraviolet absorbers,
Benzophenone derivatives, dibenzoylmethane derivatives, benzotriazole derivatives and the like have been used as UV-A absorbers and have been blended in skin external preparations. On the other hand, non-polar oils such as liquid paraffin, squalane, silicone oil, etc., which have excellent water resistance and do not easily wash off by sweat or a water bath, are required for external preparations for skin to which ultraviolet absorbers have been added in recent years, in order to maintain their effects. Bases have become widely used. Adopting these bases, not to mention the waterproof function,
It is also largely due to the ease of use, freshness, and non-greasy usability.
【0004】[0004]
【発明が解決しようとする課題】ところが、前記既存の
UV−A域の紫外線吸収剤は、非極性油基剤に対する相
溶性が著しく低いという課題があった。また、吸収剤が
一般に有色の結晶であり、製品中での低温による結晶
化、衣類の着色などの欠点があるため、その使用量が極
く少量に限られ、UV−A吸収剤のもつ機能が十分に発
揮されないという欠点があった。本発明は前記従来技術
の課題に鑑みなされたものであり、その目的は非極性油
基剤に溶解すると共に、UV−A領域の紫外線から皮膚
を保護する物質及びそれを配合した皮膚外用剤を提供す
ることにある。However, the existing UV absorbers in the UV-A region have a problem that their compatibility with a non-polar oil base is extremely low. In addition, since the absorbent is generally colored crystals, there are drawbacks such as crystallization at low temperature in products and coloring of clothes, so the amount used is extremely small, and the function of the UV-A absorbent is limited. There was a drawback that it was not fully exhibited. The present invention has been made in view of the above-mentioned problems of the prior art, and an object thereof is to dissolve a non-polar oil base and to protect the skin from ultraviolet rays in the UV-A region and a skin external preparation containing the same. To provide.
【0005】[0005]
【課題を解決するための手段】前記目的を達成するため
に本発明者らが鋭意検討した結果、スチリルケトン誘導
体が優れたUV−A吸収性及び使用性を有することを見
出し、本発明を完成するに至った。すなわち、本出願の
請求項1記載のスチリルケトン誘導体は、下記一般式化
2で表わされる。Means for Solving the Problems As a result of intensive studies by the present inventors in order to achieve the above object, they found that a styryl ketone derivative has excellent UV-A absorption and usability, and completed the present invention. Came to do. That is, the styryl ketone derivative according to claim 1 of the present application is represented by the following general formula 2.
【化2】 (但し、R’はイソプロピル基、tert−ブチル基又はイ
ソブチル基、R2,R3は炭素数1〜18の直鎖又は分岐
の、飽和または不飽和アルキル基を表わす)[Chemical 2] (However, R ′ represents an isopropyl group, a tert-butyl group or an isobutyl group, and R 2 and R 3 represent a linear or branched, saturated or unsaturated alkyl group having 1 to 18 carbon atoms.)
【0006】請求項2記載の皮膚外用剤は前記化2のス
チリルケトン誘導体を一種または二種以上を含むことを
特徴とする。The external preparation for skin according to claim 2 is characterized in that it contains one or more styryl ketone derivatives of the chemical formula 2.
【0007】以下、本発明の構成をさらに詳細に説明す
る。前記化2中、R1はイソプロピル基、tert−ブチル
基、イソブチル基であり、いずれを用いることも可能で
ある。The structure of the present invention will be described in more detail below. In the above Chemical Formula 2, R 1 is an isopropyl group, a tert-butyl group, or an isobutyl group, and any of them can be used.
【0008】R2,R3は例えばメチル基、エチル基、プ
ロピル基、イソプロピル基、ブチル基、イソブチル基、
sec−ブチル基、tert−ブチル基、ペンチル基、ネオペ
ンチル基、ヘキシル基、2−エチルブチル基、2−エチ
ルヘキシル基、イソステアリル基、アリル基、ブテニル
基、オレイル基、メチレンジオキシ基等が挙げられる
が、分岐または不飽和アルキル基が好ましい。R 2 and R 3 are, for example, methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group,
sec-butyl group, tert-butyl group, pentyl group, neopentyl group, hexyl group, 2-ethylbutyl group, 2-ethylhexyl group, isostearyl group, allyl group, butenyl group, oleyl group, methylenedioxy group and the like. However, branched or unsaturated alkyl groups are preferred.
【0009】本発明のスチリルケトン誘導体は、ジ置換
ベンズアルデヒドとメチルt−ブチルケトン又はメチル
イソプロピルケトン、メチルイソブチルケトンを溶媒中
アルカリ触媒又は酸性触媒を用いて0℃〜溶媒の沸点の
間で縮合反応を行なうことにより得ることができる。反
応に用いられる溶媒としては、例えばベンゼン、トルエ
ン、ジエチルエーテル、テトラヒドロフラン、ジオキサ
ン、ヘキサン、メチルアルコール、エチルアルコール、
ジメチルホルムアミド、ジメチルスルホキシド、ピリジ
ン、ピペリジン、水等のアルカリ又は酸に対して安定な
ものであればいずれも用いることができ、これらの混合
溶媒を用いてもよい。また、反応に用いられる触媒とし
ては、例えばピリジン、ピペリジン、ピロリジン、トリ
エチルアミン等の有機塩基、水酸化ナトリウム、水酸化
カリウム、炭酸カリウム、水素化ナトリウム、ナトリウ
ムアミド等の無機塩基、また塩酸、硫酸、p−トルエン
スルホン酸等も用いることができる。The styryl ketone derivative of the present invention undergoes a condensation reaction between disubstituted benzaldehyde and methyl t-butyl ketone or methyl isopropyl ketone or methyl isobutyl ketone in a solvent using an alkali catalyst or an acidic catalyst between 0 ° C. and the boiling point of the solvent. It can be obtained by doing. Examples of the solvent used in the reaction include benzene, toluene, diethyl ether, tetrahydrofuran, dioxane, hexane, methyl alcohol, ethyl alcohol,
Any of dimethylformamide, dimethylsulfoxide, pyridine, piperidine, water and the like which are stable to alkali or acid can be used, and a mixed solvent thereof may be used. Examples of the catalyst used in the reaction include organic bases such as pyridine, piperidine, pyrrolidine, and triethylamine, inorganic bases such as sodium hydroxide, potassium hydroxide, potassium carbonate, sodium hydride, sodium amide, hydrochloric acid, and sulfuric acid. p-Toluenesulfonic acid or the like can also be used.
【0010】本発明にかかるスチリルケトン誘導体は、
室温液体または低融点の固体であり、いずれも330〜
340nmに最大吸収を示し、UV−A吸収剤として用い
ることができる。本発明にかかる皮膚外用剤の基剤は、
前記スチリルケトン誘導体が溶解するものであればいず
れでも良いが、特に非極性油例えば流動パラフィン、ス
クワラン、シリコーン油などの基剤を用いると、のびの
良さ、さっぱり感、べとつかない等の使用感に優れ、し
かも高度の耐水性、及び汗や水に流れにくい等の機能を
得ることができる。The styryl ketone derivative according to the present invention is
Room temperature liquid or low melting point solid, both 330-
It has a maximum absorption at 340 nm and can be used as a UV-A absorber. The base of the skin external preparation according to the present invention is
Any one can be used as long as the styryl ketone derivative can be dissolved therein. Especially, when a nonpolar oil such as liquid paraffin, squalane, silicone oil or the like is used as a base, the spreadability, refreshing feeling, non-greasy feeling and the like can be improved. It is possible to obtain excellent functions such as high water resistance and difficulty in flowing into sweat or water.
【0011】本発明にかかる皮膚外用剤にシリコーン系
基剤を用いる場合、そのシリコーン系基剤は特に限定さ
れないが、例えばジメチルポリシロキサン、メチルポリ
シロキサン、メチルハイドロジェンポリシロキサンなど
の鎖状ポリシロキサン、デカメチルポリシロキサン、ド
デカメチルポリシロキサン、テトラメチルハイドロジェ
ンポリシロキサンなどの環状ポリシロキサン、ポリエー
テル、脂肪酸変性ポリシロキサン、高級アルコール変性
ポリシロキサン、アミノ変性ポリシロキサンなどが用い
得る。なお、本発明の皮膚外用剤には、通常化粧料など
に用いられる他の成分、例えば油分、潤滑油、酸化防止
剤、界面活性剤、防腐剤、金属封鎖剤、香料、水、アル
コール、増粘剤などを必要に応じて適宜配合することが
できる。When a silicone-based base is used in the external preparation for skin according to the present invention, the silicone-based base is not particularly limited. For example, a chain polysiloxane such as dimethylpolysiloxane, methylpolysiloxane and methylhydrogenpolysiloxane. , Cyclic polysiloxanes such as decamethylpolysiloxane, dodecamethylpolysiloxane, and tetramethylhydrogenpolysiloxane, polyethers, fatty acid-modified polysiloxanes, higher alcohol-modified polysiloxanes, amino-modified polysiloxanes, and the like. In addition, the external preparation for skin of the present invention includes other components usually used in cosmetics, such as oil, lubricating oil, antioxidant, surfactant, preservative, sequestering agent, perfume, water, alcohol, and increasing agent. A sticky agent or the like can be appropriately blended as necessary.
【0012】また、本発明の皮膚外用剤の剤形は任意で
あり、パウダー状、クリーム状、ペースト状、スチック
状、液状、スプレー状、ファンデーションなどいずれで
もよく、乳化剤を用いて乳化してもよい。本発明のスチ
リルケトン誘導体は、単独で用いても十分に効果を発揮
するが、必要に応じて他のUV−B吸収剤、例えばエス
カロール507(バンダイク社製)のようなp−アミノ
安息香酸誘導体、ネオヘリオパン(ハーマンアンドライ
マー社製)のようなp−メトキシ桂皮酸誘導体、サリチ
ル酸誘導体、ウロカニン酸またはその誘導体、あるいは
二酸化チタン、酸化亜鉛などの無機顔料の外、更にUV
−A吸収剤と併用することも可能である。The dosage form of the external preparation for skin of the present invention is arbitrary and may be any of powder, cream, paste, stick, liquid, spray, foundation and the like, and may be emulsified with an emulsifier. Good. The styryl ketone derivative of the present invention exerts a sufficient effect even when used alone, but if necessary, other UV-B absorber, for example, p-aminobenzoic acid such as Escarol 507 (manufactured by Bandaik). Derivatives, p-methoxycinnamic acid derivatives such as neoheliopan (manufactured by Herman Andreimer), salicylic acid derivatives, urocanic acid or its derivatives, or inorganic pigments such as titanium dioxide and zinc oxide, and UV.
It is also possible to use it together with the -A absorbent.
【0013】また、本発明におけるスチリルケトン誘導
体の配合量は、上記の剤形によって、またどの程度の紫
外線保護作用を要求するかによっても異なるが、一般に
は0.1〜20重量%、好ましくは0.5〜10重量%
である。The amount of the styryl ketone derivative used in the present invention is generally 0.1 to 20% by weight, preferably 0.1 to 20% by weight, although it varies depending on the above-mentioned dosage form and the degree of UV protection required. 0.5-10% by weight
Is.
【0014】[0014]
【実施例】以下、実施例を挙げて本発明をさらに詳細に
説明する。なお、本発明はこれらの実施例に限定される
ものではない。また、配合量は特に指定のない限り重量
%で示す。EXAMPLES The present invention will be described in more detail with reference to examples. The present invention is not limited to these examples. Further, the compounding amount is shown by weight% unless otherwise specified.
【0015】スチリルケトン誘導体の性状 本発明に用いるスチリルケトン誘導体の例として下記化
合物1〜5、及び比較化合物として2−ヒドロキシ−4
−メトキシベンゾフェノンの溶解性をシリコーン系油剤
であるシリコーンKF56(10cs 信越化学社製)及
びスクワランで試験した。 化合物1:(3-メトキシ-4-イソオクチロキシスチリル)-t-フ゛チルケトン 化合物2:(3-メトキシ-4-イソフ゛トキシスチリル)-t-フ゛チルケトン 化合物3:(3-メトキシ-4-アリルキシスチリル)-t-フ゛チルケトン 化合物4:(3-イソオクチロキシ-4-メトキシスチリル)-イソフ゜ロヒ゜ルケトン 化合物5:(2-イソオクチロキシ-3-メトキシスチリル)-イソフ゜ロヒ゜ルケトン 各化合物の室温(25℃)での溶解度(w/w)を表1に示
した。25℃で完全に透明に溶解するものについて○印
で示した。 Properties of Styryl Ketone Derivatives The following compounds 1 to 5 are examples of styryl ketone derivatives used in the present invention, and 2-hydroxy-4 is a comparative compound.
The solubility of methoxybenzophenone was tested with silicone oil, Silicone KF56 (10cs manufactured by Shin-Etsu Chemical Co., Ltd.) and squalane. Compound 1: (3-Methoxy-4-isooctyloxystyryl) -t-butylketone Compound 2: (3-Methoxy-4-isobutoxystyryl) -t-butylketone Compound 3: (3-Methoxy-4-allylxystyryl) ) -t-Butylketone compound 4: (3-isooctyloxy-4-methoxystyryl) -isopropylketone compound 5: (2-isooctyloxy-3-methoxystyryl) -isopropylketone Solubility (w of each compound at room temperature (25 ° C) / w) is shown in Table 1. The ones that are completely transparent at 25 ° C. are marked with a circle.
【表1】 ──────────────────────────────────── 性状 溶解性 シリコンKF56(50%) スクワラン(30%) ──────────────────────────────────── 化合物1 微黄色液状 ○ ○ 化合物2 微黄色粘性液状 ○ 僅かに濁る 化合物3 微黄色液状 ○ ○ 化合物4 微黄色液状 ○ ○ 化合物5 微黄色液状 ○ ○ ──────────────────────────────────── 比較化合物 黄色結晶 結晶析出 結晶析出 ──────────────────────────────────── 以上の結果、本発明にかかる化合物はいずれも優れた非
極性油溶解性を有することが理解される。[Table 1] ──────────────────────────────────── Properties Solubility Silicon KF56 (50%) Squalane (30%) ──────────────────────────────────── Compound 1 Fine yellow liquid ○ ○ Compound 2 Fine Yellow viscous liquid ○ Slightly cloudy Compound 3 slightly yellow liquid ○ ○ Compound 4 slightly yellow liquid ○ ○ Compound 5 slightly yellow liquid ○ ○ ────────────────────── ────────────── Comparative compound Yellow crystals Crystal precipitation Crystal precipitation ──────────────────────────── ──────── From the above results, it is understood that all the compounds according to the present invention have excellent non-polar oil solubility.
【0016】実施例1 (3-メトキシ-4-イソフ゛トキシスチリル)-t-フ゛チ
ルケトンの製造 3−メトキシ−4−イソブトキシベンズアルデヒド6.
9g(0.033モル)、メチル−t−ブチルケトン
3.3g(0.033モル)をエチルアルコール20ml
に溶解させ、攪拌しながら水酸化ナトリウム1.7gを
イオン交換水10mlに溶かした溶液を室温で滴下した。
滴下終了後バス温を50〜60℃に保ち4時間攪拌継続
した後、イオン交換水200mlを加えてエチルエーテル
で抽出した。溶媒を減圧留去した後、シリカゲルカラム
クロマトグラフィー(10v/v%酢酸エチル−ヘキサン混
液で溶出)で分離精製して、6.9gの微黄色粘性液体
を得た。収率は約71.7%であった。 λmax:336nm(ε=19700) マススペクトルM+m/e 290 Example 1 (3-Methoxy-4-isobutoxystyryl) -t-butyr
Preparation of Luketone 3-Methoxy-4-isobutoxybenzaldehyde 6.
20 g of ethyl alcohol containing 9 g (0.033 mol) and 3.3 g (0.033 mol) of methyl-t-butyl ketone.
A solution of 1.7 g of sodium hydroxide in 10 ml of ion-exchanged water was added dropwise at room temperature while stirring.
After completion of dropping, the bath temperature was kept at 50 to 60 ° C. and stirring was continued for 4 hours, 200 ml of ion-exchanged water was added, and the mixture was extracted with ethyl ether. After evaporating the solvent under reduced pressure, the residue was separated and purified by silica gel column chromatography (eluted with a 10 v / v% ethyl acetate-hexane mixed solution) to obtain 6.9 g of a slightly yellow viscous liquid. The yield was about 71.7%. λ max : 336 nm (ε = 19700) Mass spectrum M + m / e 290
【0017】実施例2 (3-イソオクチロキシ-4-メトキシスチリル)-イソフ゜
ロヒ゜ルケトンの製造 3−イソオクチロキシ−4−メトキシベンズアルデヒド
2.6g(0.01モル)、メチルイソプロピルケトン
0.86g(0.01モル)、水酸化ナトリウム0.6
g、イオン交換水5mlを用いて、実施例1と同様に反応
を行ない、シリカゲルカラムクロマトグラフィー(6v/
v%酢酸エチル−ヘキサン混液で溶出)で分離精製して微
黄色液体2.3gを得た。収率は約71.9%であっ
た。 λmax:333nm(ε=19500) マススペクトルM+m/e 332 以下、本発明にかかる皮膚外用剤の具体的な配合例につ
いて説明する。 Example 2 (3-Isooctyloxy-4-methoxystyryl) -isopropyl
Production of ropyl ketone 3-isooctyloxy-4-methoxybenzaldehyde 2.6 g (0.01 mol), methyl isopropyl ketone 0.86 g (0.01 mol), sodium hydroxide 0.6
g and 5 ml of ion-exchanged water, the reaction was carried out in the same manner as in Example 1, and the silica gel column chromatography (6 v /
The product was separated and purified with a v% ethyl acetate-hexane mixed solution) to obtain 2.3 g of a slightly yellow liquid. The yield was about 71.9%. λ max : 333 nm (ε = 19500) Mass spectrum M + m / e 332 Hereinafter, specific formulation examples of the external preparation for skin according to the present invention will be described.
【0018】実施例3 日焼け止化粧料(油状タイプ) (1)デカメチルシクロペンタシロキサン 47.0% (2)ジメチルポリシロキサン(10cs/25℃) 20.0 (3)メチルフェニルポリシロキサン(20cs/25℃) 18.0 (4)シリコーン樹脂 10.0 (5)エスカロール507 3.0 (6)(3-メトキシ-4-イソフ゛トキシスチリル)-t-フ゛チルケトン 2.0 <製法>(1)〜(6)を混合し、十分に溶解した後濾過して
製品とする。 <日焼け止め効果>この実施例3にかかる日焼け止化粧
料、及び(3-メトキシ-4-イソフ゛トキシスチリル)-t-フ゛チルケトン(成分
(6))を全量エスカロール507に置換した比較例(エ
スカロール507配合量5.0%)を用いて日焼け止効
果を試験した。すなわち、海浜での実使用テストにおい
て、2つのサンプルをパネル10名の体半分ずつ塗布し
分け、日焼け具合のアンケート調査及び皮膚トラブルの
調査を行なった。その結果を表2に示す。 Example 3 Sunscreen Cosmetic (Oil Type) (1) Decamethylcyclopentasiloxane 47.0% (2) Dimethylpolysiloxane (10cs / 25 ° C) 20.0 (3) Methylphenylpolysiloxane (20cs) / 25 ° C) 18.0 (4) Silicone resin 10.0 (5) Escalol 507 3.0 (6) (3-Methoxy-4-isobutoxystyryl) -t-butylketone 2.0 <Production method> (1 )-(6) are mixed, dissolved sufficiently and then filtered to obtain a product. <Sunscreen effect> The sunscreen cosmetic according to Example 3 and (3-methoxy-4-isobutoxystyryl) -t-butyl ketone (component
The sunscreen effect was tested using a comparative example (Escalol 507 content of 5.0%) in which (6)) was entirely replaced with Escalol 507. That is, in an actual use test on the beach, two samples were applied to each half of the body of 10 panelists and divided, and a questionnaire survey on the degree of sunburn and skin troubles were conducted. The results are shown in Table 2.
【表2】 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 実施例3の 比較例の サンプル塗布部 サンプル塗布部 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− パネルA ○ ○ B ○ ○ C ○ × D ○ △ E ○ × F ○ △ G △ △ H △ × I △ △ J ○ △ −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 皮膚トラブル件数 なし ひりつき3件 かゆみ 2件 発疹 1件 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 日焼けの程度の評価基準 強い日焼け症状が認められた … × 日焼け症状が認められた … △ 日焼け症状は殆ど認められなかった… ○ これらの結果よりスチリルケトン誘導体を配合した皮膚
外用剤は、従来の紫外線吸収剤(エスカロール507)
を配合した皮膚外用剤より紫外線防御効果が高く、皮膚
トラブルのない安全性が高いものであった。[Table 2] ------------------------------------------------ Sample application part of the comparative example of Example 3 Sample application part ------------------------------------------ Panel A ○○ B ○○ C ○ × D ○ △ E ○ × F ○ △ G △ △ H △ × I △ △ J ○ △ −−−−−−−−−−−−−−−−−−−−−−−−−−−−− −−−−−− Number of skin troubles None 3 Irritations 2 itching 2 Rash 1 case −−−−−−−−−−−−−−−−−−−−−−−−−−−−−− −−−−−− Evaluation Criteria for Degree of Sunburn Strong sunburn symptoms were observed. × Sunburn symptoms were observed. △ Sunburn symptoms were hardly observed. ○ From these results, skin containing styrylketone derivative was observed. The external preparation is Come of ultraviolet absorber (Esca roll 507)
The UV-protective effect was higher than that of the skin external preparation containing the compound, and the safety was high with no skin trouble.
【0019】実施例4 日焼け止化粧料(W/Oクリー
ム) (1)オクタメチルシクロテトラシロキサン 10.5% (2)ジメチルポリシロキサン(100cs) 5.0 (3)ジメチルポリシロキサン(2,500,000cs) 3.0 (4)流動パラフィン 15.0 (5)ポリエーテル変性シリコーン 6.0 (6)エスカロール507 5.0 (7)(3-メトキシ-4-イソフ゛トキシスチリル)-t-フ゛チルケトン 4.0 (8)精製水 43.1 (9)L−グルタミン酸ナトリウム 3.0 (10)1,3−ブチレングリコール 5.0 (11)防腐剤 0.2 (12)香料 0.2 <製法>(1)〜(7)、(12)を混合し、加熱溶解して70℃
に保ち油相部とする。別に(8)〜(11)を加熱溶解して7
0℃に保ち、水相部とする。この油相部に水相部を添加
して、乳化機により十分に乳化する。乳化後かき混ぜな
がら冷却し、35℃以下になったら容器に流し込み、放
冷して固める。 Example 4 Sunscreen cosmetics (W / O cream
Beam) (1) 10.5% octamethylcyclotetrasiloxane (2) Dimethyl polysiloxane (100 cs) 5.0 (3) dimethylpolysiloxane (2,500,000cs) 3.0 (4) Liquid paraffin 15.0 (5) Polyether-modified silicone 6.0 (6) Escalol 507 5.0 (7) (3-Methoxy-4-isobutoxystyryl) -t-butyl ketone 4.0 (8) Purified water 43.1 (9) L- Sodium glutamate 3.0 (10) 1,3-butylene glycol 5.0 (11) Preservative 0.2 (12) Perfume 0.2 <Production method> (1) to (7), (12) are mixed, Heat and melt to 70 ℃
Keep it in the oil phase. Separately, heat and dissolve (8) to (11) to 7
Keep it at 0 ° C and use it as the water phase part. The water phase part is added to this oil phase part, and it is sufficiently emulsified by an emulsifying machine. After emulsification, cool while stirring, and when the temperature becomes 35 ° C or lower, pour into a container and allow to cool to solidify.
【0020】実施例5 日焼け止化粧料(O/Wクリー
ム) (1)デカメチルシクロペンタシロキサン 3.0% (2)流動パラフィン 8.0 (3)イソプロピルミリステート 2.0 (4)ワセリン 4.0 (5)セタノール 4.0 (6)ステアリン酸 3.0 (7)グリセリルモノイソステアレート 3.0 (8)ネオヘリオパンAV 3.0 (9)(3-イソオクチロキシ-4-メトキシスチリル-t-フ゛チルケトン 1.0 (10)防腐剤 0.2 (11)香料 0.2 (12)グリセリン 10.0 (13)プロピレングリコール 5.0 (14)ヒアルロン酸 0.01 (15)水酸化カリウム 0.2 (16)精製水 53.39 <製法>(1)〜(11)を70℃で加熱攪拌して油相部とす
る。(12)〜(16)を70℃に加熱し完全溶解した後水相部
とする。油相部を水相部に添加し乳化機にて乳化する。
乳化物を熱交換器にて30℃まで冷却した後、充填して
製品を得る。 Example 5 Sunscreen cosmetics (O / W cream
Beam) (1) Decamethylcyclopentasiloxane 3.0% (2) Liquid paraffin 8.0 (3) Isopropyl myristate 2.0 (4) Vaseline 4.0 (5) cetanol 4.0 (6) Stearic acid 3.0 (7) Glyceryl monoisostearate 3.0 (8) Neoheliopan AV 3.0 (9) (3-isooctyloxy-4-methoxystyryl-t-butyl ketone 1.0 (10) Preservative 0.2 ( 11) Fragrance 0.2 (12) Glycerin 10.0 (13) Propylene glycol 5.0 (14) Hyaluronic acid 0.01 (15) Potassium hydroxide 0.2 (16) Purified water 53.39 <Production method> ( (1) to (11) are heated and stirred at 70 ° C. to form an oil phase part, and (12) to (16) are heated to 70 ° C. and completely dissolved to form an aqueous phase part. And emulsify with an emulsifying machine.
The emulsion is cooled to 30 ° C. in a heat exchanger and then filled to obtain a product.
【0021】実施例6 日焼け止ローション (1)ジメチルポリシロキサン(5cs) 10.0% (2)メチルフェニルポリシロキサン(20cs) 7.0 (3)ステアリン酸 1.0 (4)エスカロール507 5.0 (5)(3-メトキシ-4-イソオクチロキシスチリル)-t-フ゛チルケトン 10.0 (6)防腐剤 0.2 (7)香料 0.2 (8)グリセリン 5.0 (9)モンモリロナイト 0.5 (10)水酸化カリウム 0.2 (11)精製水 60.9 <製法>(1)〜(7)を70℃で加熱攪拌して油相部とす
る。(8)〜(11)を70℃に加熱溶解し水相部とする。油
相部を水相部中に添加し、乳化機にて乳化する。乳化物
を熱交換器にて30℃まで冷却した後に容器に充填し、
日焼け止ローションを得る。 Example 6 Sunblock Lotion (1) Dimethylpolysiloxane (5cs) 10.0% (2) Methylphenylpolysiloxane (20cs) 7.0 (3) Stearic acid 1.0 (4) Escalol 5075 0.0 (5) (3-Methoxy-4-isooctyloxystyryl) -t-butyl ketone 10.0 (6) Preservative 0.2 (7) Perfume 0.2 (8) Glycerin 5.0 (9) Montmorillonite 0.5 (10) Potassium hydroxide 0.2 (11) Purified water 60.9 <Production method> (1) to (7) are heated and stirred at 70 ° C. to form an oil phase portion. (8) to (11) are heated and dissolved at 70 ° C. to form an aqueous phase portion. The oil phase part is added to the water phase part and emulsified by an emulsifying machine. After cooling the emulsion to 30 ° C. in a heat exchanger, it is filled in a container,
Get sunblock lotion.
【0022】実施例7 日焼け止両用ファンデーション (1)シリコーン処理酸化チタン 9.5% (2)シリコーン処理マイカ 40.0 (3)シリコーン処理タルク 20.45 (4)シリコーン処理酸化鉄 7.5 (5)球状ナイロンパウダー 10.0 (6)トリメチロールプロパントリイソステアレート 5.0 (7)スクワラン 3.0 (8)ビースワックス 2.0 (9)(2-イソオクチロキシ-3-メトキシスチリル-イソフ゜ロヒ゜ルケトン 0.5 (10)ソルビタントリオレート 1.0 (11)防腐剤 0.5 (12)ビタミンE 0.05 (13)香料 0.5 <製法>(1)〜(5)をヘンシェルミキサーで混合し、これ
に(6)〜(13)を加熱溶解混合したものを添加混合した後
粉砕し、これを中皿に成形し日焼け止両用ファンデーシ
ョンを得た。 Example 7 Sunblock Foundation (1) Silicone treated titanium oxide 9.5% (2) Silicone treated mica 40.0 (3) Silicone treated talc 20.45 (4) Silicone treated iron oxide 7.5 ( 5) Spherical nylon powder 10.0 (6) Trimethylolpropane triisostearate 5.0 (7) Squalane 3.0 (8) Beeswax 2.0 (9) (2-Isooctyloxy-3-methoxystyryl-isopropylol Ketone 0.5 (10) Sorbitan trioleate 1.0 (11) Preservative 0.5 (12) Vitamin E 0.05 (13) Perfume 0.5 <Production method> (1) to (5) with a Henschel mixer After mixing, a mixture of (6) to (13) heated and dissolved and mixed was added and mixed, and then crushed, and this was molded into a medium dish to obtain a sunscreen foundation.
【0023】実施例8 日焼け止スチック化粧料 (1)酸化チタン 10.0% (2)酸化亜鉛 7.0 (3)マイカ 16.0 (4)赤色酸化鉄 1.5 (5)黄色酸化鉄 1.5 (6)黒色酸化鉄 1.0 (7)ジメチルポリシロキサン(20cs) 29.4 (8)トリメチロールプロパン−トリ−2−エチルヘキサノエート 8.0 (9)流動パラフィン 7.0 (10)マイクロクリスタリンワックス 2.0 (11)セレシン 1.0 (12)固形パラフィン 6.0 (13)エスカロール507 5.0 (14)(3-メトキシ-4-イソフ゛トキシスチリル)-t-フ゛チルケトン 3.0 (15)香料 0.5 (16)酸化防止剤 0.1 (17)ソルビタンセスキオレート 1.0 <製法>(1)〜(6)をヘンシェルミキサーで混合し、(7)
〜(9)、(13)、(14)、(16)、(17)を加熱攪拌溶解したも
のに加え混合する。次に(10)〜(12)、(15)を溶解したも
のを上記混合物に添加し、十分混合した後スチック状に
成形する。 Example 8 Sunscreen Stick Cosmetic (1) Titanium oxide 10.0% (2) Zinc oxide 7.0 (3) Mica 16.0 (4) Red iron oxide 1.5 (5) Yellow iron oxide 1.5 (6) Black iron oxide 1.0 (7) Dimethylpolysiloxane (20cs) 29.4 (8) Trimethylolpropane-tri-2-ethylhexanoate 8.0 (9) Liquid paraffin 7.0 (10) Microcrystalline wax 2.0 (11) Ceresin 1.0 (12) Solid paraffin 6.0 (13) Escalol 507 5.0 (14) (3-Methoxy-4-isobutoxystyryl) -t- Butyl ketone 3.0 (15) Perfume 0.5 (16) Antioxidant 0.1 (17) Sorbitan sesquioleate 1.0 <Production method> (1) to (6) are mixed with a Henschel mixer, and (7)
~ (9), (13), (14), (16) and (17) are added to and mixed by heating and stirring and mixing. Next, a solution obtained by dissolving (10) to (12) and (15) is added to the above mixture, mixed sufficiently, and then molded into a stick shape.
【0024】実施例9 日焼け止化粧下地 (1)スクワラン 19.0% (2)グリセリルトリイソステアレート 10.0 (3)アイソパーG 5.0 (4)ソルビタンセスキオレート 1.0 (5)ポリシロキサンエチレン変性オルガノポリシロキサン 3.0 (6)精製水 45.0 (7)1,3−ブチレングリコール 5.0 (8)微粒子酸化チタン 10.0 (9)パルソールMCX(GIVAUDAN社製) 1.0 (10)(3-イソオクチロキシ-4-メトキシスチリル)-イソフ゜ロヒ゜ルケトン 1.0 (11)防腐剤 適 量 (12)酸化防止剤 適 量 (13)香料 適 量 <製法>(1)〜(5)、(9)、(10)、(12)、(13)を70℃で
攪拌溶解し、これにあらかじめ70℃に加熱溶解した
(6)〜(8)、(11)を添加し、乳化分散後冷却して目的の日
焼け止化粧下地を得た。 Example 9 Sunscreen Makeup Base (1) Squalane 19.0% (2) Glyceryl Triisostearate 10.0 (3) Isopar G 5.0 (4) Sorbitan Sesquioleate 1.0 (5) Poly Siloxane Ethylene-modified organopolysiloxane 3.0 (6) Purified water 45.0 (7) 1,3-butylene glycol 5.0 (8) Fine particle titanium oxide 10.0 (9) Pulsol MCX (manufactured by GIVAUDAN) 1. 0 (10) (3-isooctyloxy-4-methoxystyryl) -isopropylketone 1.0 (11) Preservative proper amount (12) Antioxidant proper amount (13) Perfume proper amount <Production method> (1) to (5) ), (9), (10), (12), and (13) were dissolved by stirring at 70 ° C., and then dissolved by heating at 70 ° C. in advance.
(6) to (8) and (11) were added, emulsified and dispersed, and then cooled to obtain a desired sunscreen makeup base.
【0025】以上説明したように本発明にかかる皮膚外
用剤は、UV−A領域の紫外線を吸収し、耐水性に優れ
ており、基剤や他の配合成分を自由に選ぶことができ
る。また、日焼け止化粧料として炎天下等の苛酷な条件
下に放置した場合においても安定性に優れているという
利点を有する。また、のびがよく、さっぱり感があるべ
とつかない等の極めて優れた使用性、かつ汗や水に流れ
にくくUV−A吸収の効果が長く持続するという利点を
有している。As explained above, the external preparation for skin according to the present invention absorbs ultraviolet rays in the UV-A region and has excellent water resistance, and the base and other components can be freely selected. Further, it has an advantage that it is excellent in stability as a sunscreen cosmetic even when it is left under severe conditions such as under hot weather. Further, it has the advantages that it spreads well, has a refreshing feeling and is not sticky, and has extremely excellent usability, and that it is hard to flow into sweat or water and the effect of UV-A absorption is long-lasting.
【0026】[0026]
【発明の効果】以上説明したように本発明にかかるスチ
リルケトン誘導体によれば、優れたUV−A吸収能、及
び非極性油相溶性を有する。また、それを配合した皮膚
外用剤は非極性基剤に対しても配合可能で優れた使用性
を発揮することができる。As described above, the styryl ketone derivative according to the present invention has excellent UV-A absorption ability and nonpolar oil compatibility. Further, the external preparation for skin containing it can be compounded with a non-polar base material and can exhibit excellent usability.
【図1】本発明の一実施例にかかる(3−メトキシ−4
−イソブトキシスチリル)−t−ブチルケトンの紫外線
吸収スペクトル図である。FIG. 1 shows an example of the present invention (3-methoxy-4)
FIG. 3 is an ultraviolet absorption spectrum diagram of -isobutoxystyryl) -t-butyl ketone.
【図2】本発明の一実施例にかかる(3−メトキシ−4
−イソブトキシスチリル)−t−ブチルケトンの紫外線
吸収スペクトル図である。FIG. 2 shows (3-methoxy-4) according to one embodiment of the present invention.
FIG. 3 is an ultraviolet absorption spectrum diagram of -isobutoxystyryl) -t-butyl ketone.
Claims (2)
トン誘導体。 【化1】 (但し、R’はイソプロピル基、tert−ブチル基又はイ
ソブチル基、R2,R3は炭素数1〜18の直鎖又は分岐
の、飽和または不飽和アルキル基を表わす)1. A styryl ketone derivative represented by the following general formula 1. [Chemical 1] (However, R ′ represents an isopropyl group, a tert-butyl group or an isobutyl group, and R 2 and R 3 represent a linear or branched, saturated or unsaturated alkyl group having 1 to 18 carbon atoms.)
一種または二種以上を含むことを特徴とする皮膚外用
剤。2. A skin external preparation containing one or more styryl ketone derivatives according to claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23122991A JPH0543505A (en) | 1991-08-16 | 1991-08-16 | Styryl ketone deribvative and skin drug for external use containing the same derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23122991A JPH0543505A (en) | 1991-08-16 | 1991-08-16 | Styryl ketone deribvative and skin drug for external use containing the same derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0543505A true JPH0543505A (en) | 1993-02-23 |
Family
ID=16920347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP23122991A Withdrawn JPH0543505A (en) | 1991-08-16 | 1991-08-16 | Styryl ketone deribvative and skin drug for external use containing the same derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0543505A (en) |
-
1991
- 1991-08-16 JP JP23122991A patent/JPH0543505A/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4867964A (en) | Cosmetic composition containing hydroxylated chalcone derivatives and its use for protecting the skin and the hair against luminous radiations, new hydroxylated chalcone derivatives employed and process for their preparation | |
| JP3428104B2 (en) | Benzophenone derivatives, UV absorbers and skin external preparations | |
| RU2485936C2 (en) | Ester compounds of benzoic acid, composition (versions) and method of composition (versions) obtaining | |
| DE68925078T2 (en) | Silicon-type cinnamic acid derivatives, method for their preparation, UV absorber and external skin treatment agent | |
| JP3229383B2 (en) | Alkyl-aryl 1,3-propanedione silicone derivative and external preparation for skin containing the same | |
| JPH07206651A (en) | Ultraviolet absorber | |
| JP3497246B2 (en) | Benzylidene hydantoin derivative, ultraviolet absorber and external preparation for skin containing the same | |
| US5225583A (en) | Alkyl-aryl 1,3-propanedione silicone derivative and an external preparation for skin with the derivative compounded therein | |
| JP2860305B2 (en) | External preparation for skin | |
| JPH0717983A (en) | 5-allylpentadienoic acid silicon derivative, ultraviloet rays absorbent and skin external agent compounded with the same | |
| JPH07223932A (en) | External preparation for skin | |
| JP2003212711A (en) | Make-up cosmetic | |
| JPH06228167A (en) | Organosilicon derivative and external preparation for skin | |
| JP6105272B2 (en) | Skin external composition | |
| JPH07238275A (en) | Ultraviolet light absorber and skin external preparation containing the same blended therein | |
| JP2692473B2 (en) | Organic silicon compounds and cosmetics | |
| JPH07267842A (en) | Anti-suntan cosmetic | |
| JPH0717892A (en) | 1,3-butadienyl ketone derivative, ultraviolet ray absorber and skin external preparation containing the same blended therein | |
| JPH049355A (en) | Cinnamic acid derivative, uv absorber and dermatic external drug containing the same | |
| JPH05186429A (en) | Benzylidenehydantoin derivative and skin external preparation blended with the same | |
| JPH0543585A (en) | Styryl ketone silicone derivative and skin external preparation mixed with the same derivative | |
| JP2693659B2 (en) | Organosilicon compound and cosmetics containing the same | |
| JPH0789838A (en) | Silicone type hydantoin derivative, ultraviolet absorber and external dermatological agent | |
| JPH06107588A (en) | 1-styryl-3-t-butyl-1,3-propanedione derivative and skin external agent compounded with the same | |
| JPH04217621A (en) | Cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 19981112 |